Table 1 pre-operative baseline data
Group 1 | Group 2 | Difference (95% CI) | p value | |
|---|---|---|---|---|
Age (years) | 66.8 (±8.2) | 71.8 (±8.7) | 5.0 (1.2, 8.9) | 0.012 |
TRUS volume (cm3) | 76.1 (±35.0) | 69.3 (±31.8) | 8.5 (−24.1, 10.6) | 0.402 |
PSA (ng/mL) | 10.2 (±5.7) | 5.0 (±3.9) | 5.1 (2.5, 7.8) | < 0.001 |
Indication for HoLEP | ||||
LUTS | 11 (45.8%) | 34 (40.0%) | 5.8 (−15.0, 27.3) | 0.644 |
Refractory retention | 13 (54.2%) | 51 (60.0%) | ||
Qmax (mL/sec) | 9.9 (±4.3) | 9.6 (±5.2) | 0.4 (−3.0, 3.8) | 0.817 |
PVR (mL) | 181.4 (±99.6) | 176.8 (±140.3) | 4.6 (− 77.5, 86.8) | 0.908 |
IPSS | 22.4 (±4.7) | 22.6 (±6.9) | 0.2 (−3.7, 4.0) | 0.923 |
Quality of life score | 4.1 (±1.0) | 4.4 (±1.2) | 0.3 (−0.5, 1.1) | 0.484 |
Serum creatinine (μmol/L) | 81.0 (±16.0) | 86.7 (±30.3) | 5.7 (−3.5, 15.0) | 0.219 |